Pfizer Inc. (PFE) 재무상태표
NYSE · Healthcare · Drug Manufacturers - General · 직원 75,000명 · CEO Albert Bourla
- 주가
- $30.52 +1.90%
- 시가총액
- $1740억
- 기업가치
- $2360억
- 최근 실적
- Q2 '26 2026-08-04 제출
- 다음 실적
- 2026-11-03 EPS 추정 $0.73
Pfizer Inc. (PFE)의 Q2 '26말 현금 및 단기투자는 $117억, 리스 포함 차입금은 $632억입니다. 자산총계 $2010억, 부채총계 $1160억, 주주지분 $852억.
재무상태표
| 재무상태표 | 추세 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $31.5억 | $28.5억 | $7.19억 | $10.5억 | $10.9억 | $10.4억 | $14.3억 | $16.4억 | $13.4억 | $11.4억 | $17억 | $9.76억 | |
| 단기투자 | $410억 | $98.4억 | $112억 | $60.5억 | $88.6억 | $194억 | $159억 | $116억 | $136억 | $125억 | $114억 | $107억 | |
| 매출채권 | $150억 | $155억 | $152억 | $151억 | $177억 | $148억 | $147억 | $161억 | $181억 | $158억 | $126억 | $125억 | |
| 재고자산 | $102억 | $102억 | $109억 | $114억 | $117억 | $109억 | $109억 | $117억 | $115억 | $107억 | $107억 | $99.5억 | |
| 기타 유동자산 | $46.2억 | $49.1억 | $43.7억 | $41.9억 | $38.6억 | $42.5억 | $29.5억 | $26.9억 | $23.6억 | $28.1억 | $29.1억 | $72.2억 | |
| 유동자산 | $740억 | $433억 | $424억 | $378억 | $432억 | $504억 | $459억 | $437억 | $469억 | $429억 | $428억 | $414억 | |
| 유형자산(순액) | $179억 | $189억 | $188억 | $190억 | $185억 | $184억 | $183억 | $188억 | $189억 | $215억 | $194억 | $190억 | |
| 장기투자 | $142억 | $154억 | $116억 | $111억 | $108억 | $22.3억 | $20.1억 | $2.24억 | $21.4억 | $17.4억 | $16.3억 | $15.6억 | |
| 영업권 | $515억 | $678억 | $693억 | $684억 | $686억 | $685억 | $684억 | $690억 | $691억 | $713억 | $714억 | $714억 | |
| 무형자산 | $402억 | $649억 | $628억 | $612억 | $600억 | $554억 | $540억 | $527억 | $513억 | $537억 | $526억 | $471억 | |
| 이연법인세자산 | $83.5억 | $37.1억 | $49.4억 | $78.7억 | $79.1억 | $86.6억 | $95.4억 | $103억 | $110억 | $97억 | $99.7억 | $108억 | |
| 기타 비유동자산 | $83.9억 | $125억 | $112억 | $107억 | $105억 | $98.2억 | $98.5억 | $114억 | $93.2억 | $73억 | $98.4억 | $99.4억 | |
| 비유동자산 | $1410억 | $1830억 | $1790억 | $1780억 | $1760억 | $1630억 | $1620억 | $1620억 | $1620억 | $1650억 | $1650억 | $1600억 | |
| 자산총계 | $2150억 | $2270억 | $2210억 | $2160억 | $2190억 | $2130억 | $2080억 | $2060억 | $2090억 | $2080억 | $2080억 | $2010억 | |
| 부채 | |||||||||||||
| 매입채무 | $53.4억 | $67.1억 | $55.9억 | $51.1억 | $53.1억 | $56.3억 | $52.4억 | $51.7억 | $50.2억 | $52.4억 | $45.1억 | $45.8억 | |
| 미지급비용 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $30.4억 | $36.1억 | $27.2억 | $25.5억 | |
| 단기차입금 | $25.5억 | $103억 | $82.3억 | $119억 | $97억 | $69.5억 | $44.7억 | $43억 | $43억 | $34.8억 | $38.9억 | $27억 | |
| 미지급세금 | $19억 | $23.5억 | $31.9억 | $28.8억 | $28.8억 | $29.1억 | $0 | $36.8억 | $38억 | $0 | $31.3억 | $6.53억 | |
| 이연수익 | $22억 | $27억 | $25억 | $25.3억 | $20.2억 | $15.1억 | $10.1억 | $11.2억 | $9.24억 | $7.84억 | $6.46억 | $0 | |
| 기타 유동부채 | $191억 | $233억 | $210억 | $190억 | $233억 | $236억 | $226억 | $235억 | $195억 | $208억 | $195억 | $228억 | |
| 유동부채 | $311억 | $478억 | $405억 | $438억 | $432억 | $430억 | $365억 | $377억 | $366억 | $370억 | $343억 | $326억 | |
| 장기차입금 | $610억 | $605억 | $605억 | $567억 | $569억 | $567억 | $568억 | $575억 | $574억 | $616억 | $606억 | $605억 | |
| 리스부채(비유동) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $22.9억 | $0 | $0 | |
| 이연법인세부채 | $11.3억 | $6.4억 | $9.31억 | $22.3억 | $21.6억 | $21.2억 | $22.6억 | $24.8억 | $24.7억 | $24억 | $24.1억 | $19.6억 | |
| 기타 비유동부채 | $245억 | $283억 | $266억 | $254억 | $246억 | $231억 | $219억 | $194억 | $192억 | $181억 | $199억 | $205억 | |
| 비유동부채 | $867억 | $894억 | $880억 | $844억 | $837억 | $819억 | $809억 | $794억 | $790억 | $844억 | $829억 | $830억 | |
| 부채총계 | $1180억 | $1370억 | $1290억 | $1280억 | $1270억 | $1250억 | $1170억 | $1170억 | $1160억 | $1210억 | $1170억 | $1160억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $4.78억 | $4.78억 | $4.8억 | $4.8억 | $4.8억 | $4.8억 | $4.81억 | $4.81억 | $4.81억 | $4.81억 | $4.82억 | $4.82억 | |
| 이익잉여금 | $1260억 | $1180억 | $1210억 | $1170억 | $1210억 | $1170억 | $1200억 | $1180억 | $1210억 | $1150억 | $1170억 | $1120억 | |
| 기타포괄손익누계액 | -$79.7억 | -$79.6억 | -$77.6억 | -$78.2억 | -$79.7억 | -$78.4억 | -$85.8억 | -$84.4억 | -$80.7억 | -$80.7억 | -$72억 | -$72.2억 | |
| 주주지분 | $969억 | $890억 | $923억 | $877억 | $923억 | $882억 | $903억 | $887억 | $928억 | $865억 | $901억 | $852억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $636억 | $708억 | $687억 | $687억 | $666억 | $636억 | $613억 | $618억 | $617억 | $674억 | $645억 | $632억 | |
| 순차입금(차입금 - 현금) | $604억 | $680억 | $680억 | $676억 | $655억 | $626억 | $599억 | $602억 | $604억 | $663억 | $628억 | $622억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $26억 | $13.4억 | $11.4억 | $11.2억 | $17.9억 | $19.4억 | $4.16억 | $28.5억 | $10.4억 | $11.4억 | |
| 단기투자 | $153억 | $187억 | $177억 | $85.3억 | $104억 | $291억 | $223억 | $98.4억 | $194억 | $125억 | |
| 매출채권 | $113억 | $113억 | $114억 | $95.1억 | $112억 | $157억 | $145억 | $155억 | $148억 | $158억 | |
| 재고자산 | $67.8억 | $75.8억 | $75.1억 | $70.7억 | $80.5억 | $90.6억 | $89.8억 | $102억 | $109억 | $107억 | |
| 기타 유동자산 | $30.5억 | $23억 | $122억 | $65.8억 | $36.5억 | $38.2억 | $50.2억 | $49.1억 | $42.5억 | $28.1억 | |
| 유동자산 | $389억 | $411억 | $499억 | $328억 | $351억 | $597억 | $513억 | $433억 | $504억 | $429억 | |
| 유형자산(순액) | $133억 | $139억 | $134억 | $130억 | $137억 | $149억 | $163억 | $189억 | $184억 | $215억 | |
| 장기투자 | $71.2억 | $70.2억 | $27.7억 | $201억 | $203억 | $215억 | $151억 | $154억 | $22.3억 | $17.4억 | |
| 영업권 | $544억 | $560억 | $534억 | $482억 | $496억 | $492억 | $514억 | $678억 | $685억 | $713억 | |
| 무형자산 | $526억 | $487억 | $352억 | $339억 | $283억 | $251억 | $434억 | $649억 | $554억 | $537억 | |
| 이연법인세자산 | $18.1억 | $18.6억 | $19.2억 | $19.1억 | $23.8억 | $33.4억 | $66.9억 | $37.1억 | $86.6억 | $97억 | |
| 기타 비유동자산 | $33.2억 | $32.3억 | $28억 | $176억 | $45.7억 | $76.8억 | $132억 | $125억 | $98.2억 | $73억 | |
| 비유동자산 | $1330억 | $1310억 | $1090억 | $1350억 | $1190억 | $1220억 | $1460억 | $1830억 | $1630억 | $1650억 | |
| 자산총계 | $1720억 | $1720억 | $1590억 | $1670억 | $1540억 | $1810억 | $1970억 | $2270억 | $2130억 | $2080억 | |
| 부채 | |||||||||||
| 매입채무 | $45.4억 | $46.6억 | $46.7억 | $38.9억 | $42.8억 | $55.8억 | $68.1억 | $67.1억 | $56.3억 | $52.4억 | |
| 미지급비용 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $36.1억 | |
| 단기차입금 | $107억 | $99.4억 | $88.4억 | $162억 | $27억 | $22.4억 | $29.3억 | $103억 | $69.5억 | $34.8억 | |
| 미지급세금 | $4.37억 | $4.77억 | $12.7억 | $9.8억 | $10.5억 | $12.7억 | $15.9억 | $23.5억 | $0 | $0 | |
| 이연수익 | $0 | $0 | $0 | $0 | $11.1억 | $30.7억 | $25.2억 | $27억 | $15.1억 | $7.84억 | |
| 기타 유동부채 | $135억 | $133억 | $150억 | $141억 | $146억 | $283억 | $260억 | $233억 | $232억 | $183억 | |
| 유동부채 | $311억 | $304억 | $319억 | $373억 | $259억 | $427억 | $421억 | $478억 | $430억 | $370억 | |
| 장기차입금 | $304억 | $327억 | $329억 | $347억 | $356억 | $348억 | $319억 | $605억 | $574억 | $616억 | |
| 리스부채(비유동) | -$122억 | -$270억 | -$213억 | $10.3억 | $0 | $0 | $0 | $0 | $22.9억 | $22.9억 | |
| 이연법인세부채 | $308억 | $39억 | $37억 | $55.8억 | $40.6억 | $3.49억 | $10.2억 | $6.4억 | $21.2억 | $24억 | |
| 기타 비유동부채 | $195억 | $331억 | $272억 | $265억 | $252억 | $262억 | $262억 | $283억 | $201억 | $181억 | |
| 비유동부채 | $807억 | $697억 | $638억 | $668억 | $648억 | $613억 | $592억 | $894억 | $819억 | $844억 | |
| 부채총계 | $1120억 | $1000억 | $957억 | $1040억 | $908억 | $1040억 | $1010억 | $1370억 | $1250억 | $1210억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $4.61억 | $4.64억 | $4.67억 | $4.68억 | $4.7억 | $4.73억 | $4.76억 | $4.78억 | $4.8억 | $4.81억 | |
| 이익잉여금 | $718억 | $853억 | $896억 | $977억 | $968억 | $1030억 | $1260억 | $1180억 | $1170억 | $1150억 | |
| 기타포괄손익누계액 | -$110억 | -$93.2억 | -$113억 | -$116억 | -$117억 | -$59억 | -$83억 | -$79.6억 | -$78.4억 | -$80.7억 | |
| 주주지분 | $595억 | $713억 | $634억 | $631억 | $632억 | $772억 | $957억 | $890억 | $882억 | $865억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $411억 | $426억 | $417억 | $508억 | $383억 | $370억 | $349억 | $708억 | $670억 | $674억 | |
| 순차입금(차입금 - 현금) | $385억 | $413억 | $406억 | $497억 | $365억 | $351억 | $344억 | $680억 | $660억 | $663억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-06-28, 10-Q 2026-03-29, 10-K 2025-12-31, 10-Q 2025-09-28, 10-Q 2025-06-29, 10-Q 2025-03-30, 10-K 2024-12-31, 10-Q 2024-09-29, 10-Q 2024-06-30
데이터 기준일 2026-11-01